Wulan Apridita Sebastian

Wulan Apridita Sebastian

Auto-generated profile, based on publicly available information

Wulan Apridita Sebastian

Department of Pediatrics, Oita University, Faculty of Medicine, Oita, Japan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2024 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MIMayo Ikeuchi
Mayo Ikeuchi
MIMasanori Inoue
Masanori Inoue
HMHiroaki Miyahara
Hiroaki Miyahara
WSWulan Apridita Sebastian
Wulan Apridita Sebastian
SMShuya Miyazaki
Shuya Miyazaki
THToshikatsu Hanada
Toshikatsu Hanada

5 February 2024 in Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
WSWulan Apridita Sebastian
Wulan Apridita Sebastian
MIMasanori Inoue
Masanori Inoue
NSNobuyuki Shimizu
Nobuyuki Shimizu
RSRyosuke Sato
Ryosuke Sato
SOSaori Oguri
Saori Oguri
KIKenji Ihara
Kenji Ihara
The ACTA2 gene encodes actin α2, a major smooth muscle protein in vascular smooth muscle cells. Missense variants in the ACTA2 gene can cause inherited thoracic aortic diseases with characteristic symptoms, such as dysfunction of smooth muscle cells in the lungs, brain vessels, intestines, pupils, bladder, or heart. We identified a heterozygous missense variant of Gly148Arg (G148R) in a patient with a thoracic aortic aneurysm, dissection, and left ventricular non-compaction. We used zebrafish as an in vivo model to investigate whether or not the variants might cause functional or histopathological abnormalities in the heart. Following the fertilization of one-cell stage embryos, we injected in vitro synthesized ACTA2 mRNA of wild-type, novel variant G148R, or the previously known pathogenic variant Arg179His (R179H). The embryos were maintained and raised for 72 h post-fertilization for a heart analysis. Shortening fractions of heart were significantly reduced in both pathogenic variants. A histopathological evaluation showed that the myocardial wall of ACTA2 pathogenic variants was thinner than that of the wild type, and the total cell number within the myocardium was markedly decreased in all zebrafish with pathogenic variants mRNAs. Proliferating cell numbers were also significantly decreased in the endothelial and myocardial regions of zebrafish with ACTA2 variants compared to the wild type. These results demonstrate the effects of ACTA2 G148R and R179H on the development of left ventricle non-compaction and cardiac morphological abnormalities. Our study highlights the previously unknown significance of the ACTA2 gene in several aspects of cardiovascular development.

4 July 2023 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MAMagdeline E. Carrasco Apolinario
Magdeline E. Carrasco Apolinario
RURyohei Umeda
Ryohei Umeda
HTHitoshi Teranishi
Hitoshi Teranishi
MSMengting Shan
Mengting Shan
PHPhurpa
Phurpa
RHReiko Hanada
Reiko Hanada

22 September 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
MIMasanori Inoue
Masanori Inoue
WSWulan Apridita Sebastian
Wulan Apridita Sebastian
SSShota Sonoda
Shota Sonoda
HMHiroaki Miyahara
Hiroaki Miyahara
NSNobuyuki Shimizu
Nobuyuki Shimizu
KIKenji Ihara
Kenji Ihara
Acute liver failure is a life-threatening condition during infancy. Biallelic pathogenic variants in LARS1 cause infantile liver failure syndrome type 1 (ILFS1), which is characterized by acute hepatic failure in infants. LARS functions as a protein associated with mTORC1 and plays a crucial role in amino acid-triggered mTORC1 activation and autophagy regulation. A previous study demonstrated that larsb -knockout zebrafish show a condition resembling ILFS. However, a comprehensive analysis of larsb -knockout zebrafish has not yet been performed because of early mortality. We herein generated a long-term viable zebrafish model carrying a LARS1 variant identified in an ILFS1 patient ( larsb-I451 F zebrafish) and analyzed the pathogenesis of the affected liver of ILFS1. Hepatic dysfunction is most prominent in ILFS1 patients during infancy; correspondingly, the larsb-I451F zebrafish manifested hepatic anomalies during the developmental stages. The larsb-I451F zebrafish demonstrates augmented lipid accumulation within the liver under autophagy activation. Inhibition of DGAT1, which converts fatty acids to triacylglycerols, improved lipid droplets in the liver of larsb-I451F zebrafish. Notably, treatment with an autophagy inhibitor ameliorated hepatic lipid accumulation in this model. Our findings suggested that enhanced autophagy caused by biallelic LARS1 variants contributes to ILFS1-associated hepatic dysfunction. Furthermore, the larsb-I451F zebrafish model, which has a prolonged survival rate compared to the larsb -knockout model, highlights its potential utility as a tool for investigating the pathophysiology of ILFS1-associated liver dysfunction. Author Summary: Infantile liver failure (ALF) is a rare but life-threatening condition primarily caused by various genetic and infectious factors during infancy. Comprehensive research into its causes is crucial for treatment decisions, including liver transplantation and supportive interventions. While specific therapies exist for some conditions, a significant proportion of infant ALF cases remains unresolved. Recent advances in genetic sequencing have identified congenital disorders, particularly involving the LARS1 gene, as contributors to ALF. LARS1 is essential for regulating processes related to amino acids and autophagy. To better understand this condition, we created a zebrafish model carrying specific LARS1 gene variants seen in ALF patients. These zebrafish displayed liver abnormalities similar to those observed in infants with ALF. Our study revealed that enhanced autophagy, triggered by biallelic LARS1 variants, plays a significant role in liver dysfunction associated with ALF. Notably, inhibiting specific enzymes involved in fat metabolism and autophagy showed promising results in reducing hepatic lipid accumulation in our zebrafish model. This research provides insights that may lead to improved understanding and potential treatments for this devastating condition.